1
|
Graham HR, Olojede OE, Bakare AAA, McCollum ED, Iuliano A, Isah A, Osebi A, Seriki I, Ahmed T, Ahmar S, Cassar C, Valentine P, Olowookere TF, MacCalla M, Uchendu O, Burgess RA, Colbourn T, King C, Falade AG. Pulse oximetry and oxygen services for the care of children with pneumonia attending frontline health facilities in Lagos, Nigeria (INSPIRING-Lagos): study protocol for a mixed-methods evaluation. BMJ Open 2022; 12:e058901. [PMID: 35501079 PMCID: PMC9062461 DOI: 10.1136/bmjopen-2021-058901] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/04/2022] Open
Abstract
INTRODUCTION The aim of this evaluation is to understand whether introducing stabilisation rooms equipped with pulse oximetry and oxygen systems to frontline health facilities in Ikorodu, Lagos State, alongside healthcare worker (HCW) training improves the quality of care for children with pneumonia aged 0-59 months. We will explore to what extent, how, for whom and in what contexts the intervention works. METHODS AND ANALYSIS Quasi-experimental time-series impact evaluation with embedded mixed-methods process and economic evaluation. SETTING seven government primary care facilities, seven private health facilities, two government secondary care facilities. TARGET POPULATION children aged 0-59 months with clinically diagnosed pneumonia and/or suspected or confirmed COVID-19. INTERVENTION 'stabilisation rooms' within participating primary care facilities in Ikorodu local government area, designed to allow for short-term oxygen delivery for children with hypoxaemia prior to transfer to hospital, alongside HCW training on integrated management of childhood illness, pulse oximetry and oxygen therapy, immunisation and nutrition. Secondary facilities will also receive training and equipment for oxygen and pulse oximetry to ensure minimum standard of care is available for referred children. PRIMARY OUTCOME correct management of hypoxaemic pneumonia including administration of oxygen therapy, referral and presentation to hospital. SECONDARY OUTCOME 14-day pneumonia case fatality rate. Evaluation period: August 2020 to September 2022. ETHICS AND DISSEMINATION Ethical approval from University of Ibadan, Lagos State and University College London. Ongoing engagement with government and other key stakeholders during the project. Local dissemination events will be held with the State Ministry of Health at the end of the project (December 2022). We will publish the main impact results, process evaluation and economic evaluation results as open-access academic publications in international journals. TRIAL REGISTRATION NUMBER ACTRN12621001071819; Registered on the Australian and New Zealand Clinical Trials Registry.
Collapse
Affiliation(s)
- Hamish R Graham
- Centre for International Child Health, MCRI, University of Melbourne, The Royal Children's Hospital Melbourne, Parkville, Victoria, Australia
- Department of Paediatrics, University College Hospital Ibadan, Ibadan, Oyo, Nigeria
| | - Omotayo E Olojede
- Department of Paediatrics, University College Hospital Ibadan, Ibadan, Oyo, Nigeria
| | - Ayobami Adebayo A Bakare
- Department of Global Public Health, Karolinska Institutet, Stockholm, Sweden
- Department of Community Medicine, University College Hospital Ibadan, Ibadan, Oyo, Nigeria
| | - Eric D McCollum
- Eudowood Division of Pediatric Respiratory Sciences, Department of Paediatrics, School of Medicine, Johns Hopkins University, Baltimore, Maryland, USA
| | - Agnese Iuliano
- Institute for Global Health, University College London, London, UK
| | - Adamu Isah
- Save the Children International, Abuja, FCT, Nigeria
| | - Adams Osebi
- Save the Children International, Abuja, FCT, Nigeria
| | | | | | | | | | | | | | | | - Obioma Uchendu
- Department of Community Medicine, University College Hospital Ibadan, Ibadan, Oyo, Nigeria
- Department of Community Medicine, University of Ibadan, Ibadan, Oyo, Nigeria
| | | | - Timothy Colbourn
- Institute for Global Health, University College London, London, UK
| | - Carina King
- Department of Global Public Health, Karolinska Institutet, Stockholm, Sweden
- Institute for Global Health, University College London, London, UK
| | - Adegoke G Falade
- Department of Paediatrics, University College Hospital Ibadan, Ibadan, Oyo, Nigeria
- Department of Paediatrics, University of Ibadan, Ibadan, Oyo, Nigeria
| |
Collapse
|
2
|
Graham HR, Olojede OE, Bakare AA, Iuliano A, Olatunde O, Isah A, Osebi A, Ahmed T, Uchendu OC, Burgess R, McCollum E, Colbourn T, King C, Falade AG. Measuring oxygen access: lessons from health facility assessments in Lagos, Nigeria. BMJ Glob Health 2021; 6:bmjgh-2021-006069. [PMID: 34344666 PMCID: PMC8336153 DOI: 10.1136/bmjgh-2021-006069] [Citation(s) in RCA: 11] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/21/2021] [Accepted: 06/24/2021] [Indexed: 12/20/2022] Open
Abstract
The COVID-19 pandemic has highlighted global oxygen system deficiencies and revealed gaps in how we understand and measure 'oxygen access'. We present a case study on oxygen access from 58 health facilities in Lagos state, Nigeria. We found large differences in oxygen access between facilities (primary vs secondary, government vs private) and describe three key domains to consider when measuring oxygen access: availability, cost, use. Of 58 facilities surveyed, 8 (14%) of facilities had a functional pulse oximeter. Oximeters (N=27) were typically located in outpatient clinics (12/27, 44%), paediatric ward (6/27, 22%) or operating theatre (4/27, 15%). 34/58 (59%) facilities had a functional source of oxygen available on the day of inspection, of which 31 (91%) facilities had it available in a single ward area, typically the operating theatre or maternity ward. Oxygen services were free to patients at primary health centres, when available, but expensive in hospitals and private facilities, with the median cost for 2 days oxygen 13 000 (US$36) and 27 500 (US$77) Naira, respectively. We obtained limited data on the cost of oxygen services to facilities. Pulse oximetry use was low in secondary care facilities (32%, 21/65 patients had SpO2 documented) and negligible in private facilities (2%, 3/177) and primary health centres (<1%, 2/608). We were unable to determine the proportion of hypoxaemic patients who received oxygen therapy with available data. However, triangulation of existing data suggested that no facilities were equipped to meet minimum oxygen demands. We highlight the importance of a multifaceted approach to measuring oxygen access that assesses access at the point-of-care and ideally at the patient-level. We propose standard metrics to report oxygen access and describe how these can be integrated into routine health information systems and existing health facility assessment tools.
Collapse
Affiliation(s)
- Hamish R Graham
- Centre for International Child Health, MCRI, University of Melbourne, Royal Children's Hospital, Parkville, Victoria, Australia .,Department of Paediatrics, University College Hospital Ibadan, Ibadan, Oyo, Nigeria
| | - Omotayo E Olojede
- Department of Paediatrics, University College Hospital Ibadan, Ibadan, Oyo, Nigeria
| | - Ayobami A Bakare
- Department of Community Medicine, University College Hospital Ibadan, Ibadan, Oyo, Nigeria.,Institute for Global Health, Karolinska Institute, Stockholm, Sweden
| | - Agnese Iuliano
- Institute for Global Health, University College London, London, UK
| | - Oyaniyi Olatunde
- Department of Paediatrics, University College Hospital Ibadan, Ibadan, Oyo, Nigeria
| | - Adamu Isah
- Save the Children Nigeria, Abuja, FCT, Nigeria
| | - Adams Osebi
- Save the Children Nigeria, Abuja, FCT, Nigeria
| | | | - Obioma C Uchendu
- Department of Community Medicine, University College Hospital Ibadan, Ibadan, Oyo, Nigeria.,Department of Community Medicine, University of Ibadan, Ibadan, Oyo, Nigeria
| | - Rochelle Burgess
- Institute for Global Health, University College London, London, UK
| | - Eric McCollum
- Global Program in Respiratory Sciences, Eudowood Division of Pediatric Respiratory Sciences, Department of Pediatrics, Johns Hopkins School of Medicine, Baltimore, Maryland, USA
| | - Tim Colbourn
- Institute for Global Health, University College London, London, UK
| | - Carina King
- Institute for Global Health, University College London, London, UK.,Global Public Health, Karolinska Institutet, Stockholm, Sweden
| | - Adegoke G Falade
- Department of Paediatrics, University College Hospital Ibadan, Ibadan, Oyo, Nigeria.,Department of Paediatrics, University of Ibadan, Ibadan, Oyo, Nigeria
| | | |
Collapse
|